Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergen-induced airway hyperresponsiveness.

P M O'Byrne1

  • 1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

The Journal of Allergy and Clinical Immunology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018
Same author

Sputum cytology during late-phase responses to inhalation challenge with different allergens.

Allergy·2018
Same author

Toll-like receptor-induced expression of epithelial cytokine receptors on haemopoietic progenitors is altered in allergic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same author

A dual CysLT<sub>1/2</sub> antagonist attenuates allergen-induced airway responses in subjects with mild allergic asthma.

Allergy·2016
Same author

Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma.

Clinical pharmacology and therapeutics·2015
Same journal

Corrigendum.

The Journal of allergy and clinical immunology·2026
Same journal

Comparative Efficacy of Biologic Agents for Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Network Meta-analysis.

The Journal of allergy and clinical immunology·2026
Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026
Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026
Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026
See all related articles

Allergen inhalation triggers early and late asthmatic responses, increasing airway hyperresponsiveness. Inflammatory mediators like leukotriene B4 and platelet-activating factor are implicated in this asthma pathogenesis.

Area of Science:

  • Pulmonary immunology
  • Allergic airway inflammation

Background:

  • Allergen inhalation causes early and late asthmatic responses.
  • Environmental allergen exposure exacerbates asthma symptoms and treatment needs.
  • Airway hyperresponsiveness is linked to acute inflammatory responses.

Purpose of the Study:

  • To investigate the mechanisms underlying allergen-induced airway inflammation and hyperresponsiveness.
  • To identify key mediators involved in the pathogenesis of asthma.
  • To understand the relationship between inflammation and airway hyperresponsiveness.

Main Methods:

  • Inhalation of allergens in laboratory settings and analysis of animal models and sensitized human subjects.
  • Assessment of early (0-2 hours) and late (3-12 hours) asthmatic responses.

Related Experiment Videos

  • Evaluation of airway hyperresponsiveness to bronchoconstrictor mediators.

    • Main Results:

    • Allergen inhalation induces acute airway inflammation with neutrophil and/or eosinophil influx.
    • Airway hyperresponsiveness develops as a consequence of the inflammatory response.
    • Leukotriene B4 and platelet-activating factor can initiate airway inflammation and hyperresponsiveness.
    • Cyclooxygenase products, potentially thromboxane, may play a role in allergen-induced airway hyperresponsiveness in some animal models.

    Conclusions:

    • Allergen inhalation is a significant trigger for asthmatic responses and airway hyperresponsiveness.
    • The inflammatory response following allergen exposure is central to the development of airway hyperresponsiveness.
    • Specific inflammatory mediators, including chemotactic factors and cyclooxygenase products, are implicated in asthma pathogenesis.